Skip to main content
. 2022 Jan 15;2022:4004068. doi: 10.1155/2022/4004068

Table 3.

The pharmacokinetic properties prediction by SwissADME software.

Ligand GI absorption Cytochrome inhibitor Bioavailability
1 2 3 4 5
b High Yes Yes Yes Yes No 0.85
c Low Yes Yes No Yes Yes 0.55
9ІV-c Low NO Yes Yes No No 0.55

1: CYP1A2; 2: CYP2C19; 3: CYP2C9; 4: CYP2D6; 5: CYP3A4.